Speakers
will include:
Michael
Ashburner, University
of Cambridge
Dr.
Ashburner is Professor of Biology in the Department of Genetics.
He has contributed significantly to the field of biomedical ontology,
primarily through his leadership role in both the Gene Ontology
Consortium and the Open Biological Ontologies Project.
Steven
Gordon, Cleveland Clinic
Dr. Gordon is Chairman of the Department of Infectious Diseases
in the Cleveland Clinic's Division of Medicine with a long-term
interest in the prevention and treatment of transplant infectious
diseases, cardiothoracic infections, and healthcare associated
infections. His work embraces the development and evaluation of
innovative infectious disease diagnostics, including the planned
development of an infectious disease ontology covering infections
problematic in surgical contexts.
Stefan Kaufmann, Max Planck Institute for
Infection Biology, Germany
Dr. Kaufmann is Director of the Department of Immunology
at the Max Planck Institute for Infection Biology in Berlin and
Professor of Microbiology and Immunology at the Charité,
Humboldt University, Berlin. Dr. Kaufmann has made significant
contributions towards our understanding of immunity to bacterial
pathogens resulting in advances in the development of a tuberculosis
vaccine. Dr. Kaufmann's research has focuses specifically in the
following areas: tuberculosis gene expression at different sites
within the lung, biomarkers for discrimination between latent
infection and active disease, and the role of T cells, especially
regulatory T cells, in the immune response to tuberculosis.
Ronald Veazey, Tulane University
Dr. Veazey is Professor of Pathology and Chair of the Division
of Comparative Pathology for the Tulane National Primate Research
Center. His research on SIV in non-human primates has made significant
contributions to our understanding of HIV transmissibility and
pathogenesis. His seminal work demonstrating that early events
in viral transmission and replication occur primarily in the intestinal
and vaginal mucosa has led to a shift in focus in HIV research
from blood to mucosal immunity and has led to significant efforts
to develop topical microbicides.
Schedule
8.30-9.00 Registration and Coffee / Continental Breakfast
9.00-9.05 Introduction and Welcome (Barry Smith and Lindsay
Cowell)
Session
I: Topics in Infectious Disease Research
9:05 to 10:15 Stefan Kaufmann: Global Threats Need Global
Research Efforts: The Example of Tuberculosis
10:15 to 11:15 Ron Veazey: Utility of nonhuman primates for
examining transmission and pathogenesis of HIV infection
11:15 to 11:30 coffee break
Session
II: Ontologies and their Application to Infectious Disease
11:30 to 12:30 Steve Gordon: Surgical Endocarditis: Bringing
Ontology into the Operating Room
12:30 to 1:30 lunch
1:30 to 2:45 Michael Ashburner: Ontologies for Biomedicine:
The GO experience
2:45 to 3:00 break
Session
III: Panel Session - Ontology and the Future of Infectious Disease
Research
3:00 to 4:30
Lindsay Cowell, Duke University Medical Center
Richard Scheuermann, University of Texas Southwestern Medical
Center
Barry Smith, University at Buffalo
Lincoln Stein, Cold Spring Harbor Laboratory
This
meeting is supported by
The Burroughs Wellcome Fund.
Pricing
Academic Package $150
Student Package $100
Corporate Package $295
Currency
converter Packages are all inclusive and cover registration, parking, refreshments, lunch and dinner. Full payment is due
4 weeks prior to the meeting.
